Merit Medical Systems to Announce Fourth Quarter and Year End 2019 Results on February 24, 2020

NEXT STORY
Innovation Pharmaceuticals Phase 1 Trial of Brilacidin for Ulcerative Colitis Meets Primary Endpoints; Positive Topline Results of Oral Brilacidin
PREV STORY
The global veterinary CROs market is expected to reach US$ 1,440.15 Mn in 2027 from US$ 710.81 Mn in 2019
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

ContraFect to Present at Piper Jaffray Health Care Conference

YONKERS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology ...

author_avatar
NASDAQ Market News

Translate Bio Appoints Robert Meyer, MD, to its Board of Directors

Appointment adds regulatory expertise as Translate Bio advances early and mid-stage pipeline programsLEXINGTON, Mass., ...

author_avatar
NASDAQ Market News

Hospital/Medical Beds Market Worth USD 3.14 Billion by 2023, Says Meticulous Research®

LONDON, Sept. 03, 2018 (GLOBE NEWSWIRE) -- According to this latest publication from Meticulous ...

author_avatar
NASDAQ Market News